News in brief: Cannaponics raise tops $2.5m; Avecho receives $1.98m R&D incentive; Elixinol backs capital raising plans by Adam Sheldon May 27, 2026May 28, 2026 Cannaponics’ capital raise on OnMarket has attracted more than $2.5 million from almost 1,300 investors ahead […]
E-commerce surge lifts Elixinol margins in FY25 but losses deepen by Adam Sheldon March 3, 2026March 5, 2026
Elixinol records first underlying operating cash flow positive quarter by Adam Sheldon February 2, 2026February 3, 2026
Elixinol names new chair in pursuit of ‘sustainable and profitable business’ by Steve Jones December 2, 2025February 21, 2026
News in brief: Elixinol names new CEO; Aurora flags MedReleaf growth; InhaleRx R&D tax rebate; ODC to ‘share insights’; Tilray appoints new Australian director by Steve Jones June 20, 2025June 26, 2025
News in brief: Carmen Doran to chair NZMCC; ECS Botanics tips record harvest; Elixinol and Epsilon raise capital by Martin Lane and Steve Jones May 21, 2025May 21, 2025
Elixinol Wellness snaps up lifestyle brand The Healthy Chef by Martin Lane October 4, 2024January 13, 2025
Company news: Cann Group; Helius Therapeutics/Novachem; Elixinol/HFA by Martin Lane September 4, 2024January 13, 2025
Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne by Martin Lane and Steve Jones September 2, 2024September 3, 2024
